HSPA9 and cholestasis: Perturbations in genes associated with steatosis, cholestasis and phospholipidosis were particularly evident across the three livers with APAP (18 genes, 25%), DCF (15 genes, 22.4%), DTL (21 genes, 20.5%) and CSA (17 genes, 19.8%), followed by CBZ (13 genes, 19.5%), TBF (14 genes, 19.1%), ETM (14 genes, 18.1%), and MMI (11 genes, 23.3%).